Lansap in treatment of esophagitis in patients with systemic sclerosis

Objective. To study the efficacy of Lansap (Lansoprasole) in treatment of esophagitis in pts with systemic sclerosis (SS). Methods. 30 SS pts with clinical manifestations and endoscopic signs of esophagitis received lansap 30 or 60 mg/day during two weeks. All pts had a standard endoscopic examinati...

Full description

Bibliographic Details
Main Authors: R T Alekperov, A E Karateev, N G Guseva
Format: Article
Language:Russian
Published: IMA PRESS LLC 2003-04-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/901